PG Officer Reports 62,338-Share Option Exercise; 27,295 Shares Disposed
Rhea-AI Filing Summary
Ma. Fatima Francisco, an officer at Procter & Gamble Co (PG), reported transactions dated 10/01/2025. The filing shows a disposition of 27,295.0856 shares of Common Stock and an acquisition via option exercise of 62,338 shares (stock option with exercise price $153.18), resulting in 62,338 shares held directly after the exercise. Post-transaction indirect holdings include 15,998.3673 shares held by a retirement plan trustee and 2,862.8125 shares held indirectly by spouse and plan trustees. The form includes an explanatory note that the figures reflect an adjustment to PST through September 30, 2025. The report is signed by an attorney-in-fact on 10/02/2025.
Positive
- 62,338 shares acquired via option exercise at $153.18 (direct ownership)
- Filing discloses indirect holdings by a retirement plan trustee, clarifying beneficial ownership
Negative
- 27,295.0856 shares disposed of on 10/01/2025
- Signatory is an attorney-in-fact rather than the reporting person, indicating a proxy signature
Insights
Form 4 records an option exercise plus share disposition on 10/01/2025.
The filing documents an option exercise creating 62,338 directly held shares at an exercise price of $153.18, and a contemporaneous reported disposition of 27,295.0856 shares. The explanation line states these amounts reflect an adjustment to PST through 9/30/2025, which clarifies the timing of internal account adjustments.
This Form 4 follows required Section 16 reporting: the signature is by an attorney-in-fact on 10/02/2025, and the filing lists indirect holdings by a retirement plan trustee and spouse.
Officer-level transaction shows both acquisition and disposition activity.
The reporting person is identified as an officer (CEO - Baby, Fem & Family Care), indicating insider-level trades. The filing separates direct ownership (62,338 shares) from indirect holdings (15,998.3673 and 2,862.8125 shares) which is standard for retirement plan and spouse attribution.
No additional restrictions, waivers, or amendments are disclosed in this filing.